
SpringWorks Therapeutics Investor Relations Material
Latest events

Q3 2024
SpringWorks Therapeutics

Q1 2025
8 May, 2025

Q4 2024
20 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SpringWorks Therapeutics Inc
Access all reports
SpringWorks Therapeutics Inc. is a biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company leverages a precision medicine approach to develop therapies that target critical pathways in these diseases. SpringWorks' portfolio includes investigational therapies designed to modulate the activity of key proteins and signaling pathways involved in disease progression. The company collaborates with other pharmaceutical firms and research institutions to advance its clinical programs and bring innovative treatments to market. The company is headquartered in Stamford, Connecticut, and its shares are listed on the NASDAQ.
Key slides for SpringWorks Therapeutics Inc


Corporate Presentation
SpringWorks Therapeutics Inc


Corporate Presentation
SpringWorks Therapeutics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SWTX
Country
🇺🇸 United States